Best TWAS P=1.26e-15 · Best GWAS P=2.28e-13 conditioned to 0.675
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | GSDMC | 0.03 | 0.01 | blup | 57 | 0.02 | 1.4e-02 | -7.3 | -6.7 | 2.2e-11 | 0.95 | 0.01 | 0.89 | FALSE |
2 | The Cancer Genome Atlas | Breast Invasive Carcinoma | GSDMC | 0.05 | 0.06 | lasso | 7 | 0.05 | 1.5e-10 | -7.3 | -7.7 | 9.7e-15 | 0.94 | 0.00 | 1.00 | FALSE |
3 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | GSDMC | 0.21 | 0.14 | blup | 57 | 0.15 | 1.2e-07 | -7.2 | -7.2 | 5.6e-13 | 0.81 | 0.01 | 0.99 | FALSE |
4 | The Cancer Genome Atlas | Colon Adenocarcinoma | GSDMC | 0.13 | 0.08 | lasso | 7 | 0.09 | 5.0e-06 | -6.8 | -6.8 | 1.3e-11 | 0.92 | 0.01 | 0.99 | FALSE |
5 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | GSDMC | 0.25 | 0.30 | lasso | 5 | 0.32 | 4.6e-36 | -7.3 | -7.4 | 1.9e-13 | 0.99 | 0.00 | 1.00 | FALSE |
6 | The Cancer Genome Atlas | Lung Adenocarcinoma | GSDMC | 0.09 | 0.03 | enet | 5 | 0.06 | 7.0e-08 | -6.8 | -6.3 | 2.4e-10 | 0.79 | 0.02 | 0.97 | FALSE |
7 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | GSDMC | 0.16 | 0.14 | blup | 57 | 0.15 | 6.3e-17 | -6.7 | -6.7 | 1.8e-11 | 0.88 | 0.05 | 0.95 | FALSE |
8 | The Cancer Genome Atlas | Prostate Adenocarcinoma | GSDMC | 0.03 | 0.02 | blup | 57 | 0.02 | 1.4e-03 | -7.3 | -8.0 | 1.3e-15 | 0.94 | 0.01 | 0.93 | TRUE |
9 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | GSDMC | 0.21 | 0.05 | blup | 57 | 0.06 | 1.2e-02 | -7.2 | -6.0 | 1.8e-09 | 0.83 | 0.01 | 0.77 | FALSE |